Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.
about
Mast Cell: A Multi-Functional Master CellOrganic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative StressTargeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin systemAldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cellsMitochondria as a source and target of lipid peroxidation products in healthy and diseased heartHistamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C ε-dependent aldehyde dehydrogenase type-2 activationMitochondrial aldehyde dehydrogenase-2 deficiency compromises therapeutic effect of ALDH bright cell on peripheral ischemiaInteraction between sensory C-fibers and cardiac mast cells in ischemia/reperfusion: activation of a local renin-angiotensin system culminating in severe arrhythmic dysfunctionMitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function.Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.Aldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory painTelmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor γ.E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications.Sex differences in inflammation during atherosclerosis.Mast Cell Proteases and InflammationHistamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.Aldehyde dehydrogenase type 2 activation by adenosine and histamine inhibits ischemic norepinephrine release in cardiac sympathetic neurons: mediation by protein kinase Cε.Adenosine receptor targeting in health and disease.Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease.The role of mast cells in ischemia and reperfusion injury.Molecular pathways of arterial aging.AMP-dependent kinase and autophagic flux are involved in aldehyde dehydrogenase-2-induced protection against cardiac toxicity of ethanolmTOR-STAT3-notch signalling contributes to ALDH2-induced protection against cardiac contractile dysfunction and autophagy under alcoholismIncreased expression of microRNA-378a-5p in acute ethanol exposure of rat cardiomyocytes.Regulation of the Cardiovascular System by Histamine.A non-cardiomyocyte autonomous mechanism of cardioprotection involving the SLO1 BK channel.Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function.ALDH2, a novel protector against stroke?Inhibition of ALDH2 expression aggravates renal injury in a rat sepsis syndrome modelIgE receptor-mediated mast-cell renin releaseALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress.Mast Cells Play an Important Role in the Pathogenesis of Hyperglycemia-Induced Atrial Fibrillation.Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes.
P2860
Q26771463-88297EBA-55F5-46D8-92B2-0CC9DD4B6843Q26799354-CEC994AF-34B5-4E9E-96A2-62CA6B13F7D1Q27026966-3226AE2E-0876-4F65-B760-8F0CB60A88B2Q28078884-7240D555-243E-4975-B592-D02B2D571AFBQ28391033-4B8A1D6C-6BF0-446F-9D97-D1DF066B5F9DQ33603610-2BDBD178-F3DC-4675-B7C8-3853CF93FEE5Q33763629-6F320ED7-78EF-4B9C-ABCD-2AD570F9B750Q34214709-ED5A7215-1ED4-4B72-81E0-D1D332596D0EQ34242002-3020AE8D-CA1A-4022-9916-FD24F7D02017Q34395219-0EA693E7-F5AD-438D-AF47-9B4E4917AEAAQ34522391-194561E3-B1EA-4206-BE82-CEB1D6DB7936Q34759513-720049E1-A1A3-493B-9C3E-7D5384E1EA39Q34847699-13DEE813-2FAE-4CEF-848B-1BCA0AC50136Q35129038-DF7BBEAD-E0A3-4435-AE1B-6720069A3F46Q35509492-0BA10E05-8A68-4300-930E-B1AE6F63CCE3Q35572708-4E359A7C-891D-4E6B-AF10-02D52880706AQ35650739-01009D80-45AA-4D75-8AFD-3AE87949E0D5Q36296888-506A060C-EC72-4CDF-BC49-0BC518CFFC3EQ37948081-9F58DA8B-A808-45F1-913D-06233D67754EQ38163001-60814FA8-6C0B-40FA-9D7D-FA44793F2191Q38238437-E97958F1-5E76-4551-9A2C-82680C05A584Q38252544-7AAD2D44-7396-4F7A-A9B4-BE3AF3DDE11DQ38642240-24FA7F54-91CA-4858-A4BE-96162D1B3111Q38840550-F6453F75-7BDB-4E55-B6E4-FFD17FA26E9BQ38979695-DE7485A8-AD18-43C0-943F-490425602F11Q39006801-1D8759DC-1100-4B04-BD46-FB0B3F88F24CQ39896013-4937D2AF-E188-42A4-8135-158B33B9508CQ41089202-D2C45269-6E1C-4167-81F2-19CF49361DC3Q41354668-6B1D3170-BDA2-4143-96A0-B1DCC2081A68Q41672296-B953ACCE-039F-426C-A147-A7BF7508D209Q41899457-C19890C2-85A7-4060-AA6A-E1D4C6E249D7Q42061022-49A05B10-04CC-44FF-A72A-4F7FB75F7FFCQ46560683-6476C182-4A7A-4FD9-8E00-07FDD9242106Q49830046-49EF2F87-1EBA-4149-8241-9E6CAA72DBF8
P2860
Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Aldehyde dehydrogenase activat ...... lease from cardiac mast cells.
@en
Aldehyde dehydrogenase activat ...... lease from cardiac mast cells.
@nl
type
label
Aldehyde dehydrogenase activat ...... lease from cardiac mast cells.
@en
Aldehyde dehydrogenase activat ...... lease from cardiac mast cells.
@nl
prefLabel
Aldehyde dehydrogenase activat ...... lease from cardiac mast cells.
@en
Aldehyde dehydrogenase activat ...... lease from cardiac mast cells.
@nl
P2093
P2860
P1433
P1476
Aldehyde dehydrogenase activat ...... lease from cardiac mast cells.
@en
P2093
Kenichiro Koda
Mariselis Salazar-Rodriguez
Noel Yan-Ki Chan
Racha Estephan
Randi B Silver
Roberto Levi
P2860
P304
P356
10.1161/CIRCULATIONAHA.110.952481
P407
P577
2010-08-09T00:00:00Z